Diabetic retinopathy is a leading cause of blindness among working age people worldwide. But thanks to the Diabetic Eye Screening Programme and an improved understanding of the impact of glycaemic control on diabetic retinopathy, there has been a significant reduction in the level of sight-loss in England and Wales. By catching the early signs of disease, eye care practitioners play a vital role in preventing the worst outcomes, such as proliferative retinopathy and diabetic macular oedema. Can this positive trend continue?
In this episode, Michelle Hanratty speaks to Dr Rosalind (Rosie) Creer, a Lead Optometrist for Diabetes at Manchester Royal Eye Hospital. Rosie emphasised how blood sugar control is directly linked to retinopathy progression, how to differentiate between different types of lesions and why the recent changes that have been made to eye screening programmes could affect optometrists.
Rosie also presented Docet’s recent webinar, called, “
Joining the Dots (and Blots) of Diabetic Retinopathy” and answers some of the questions that optometrists left during that session.
Find more information on the Diabetic Eye Screening Programme (and grading criteria) in
England,
Wales and
Northern Ireland on the nations’ public health websites.
This is our 50th episode of Sound Optometry and we’ve had more than one hundred thousand listens over the last five years. Thank you so much for continuing to support our podcast. Don’t forget that if you have a topic in mind that you’d like us to cover, or if you’ve got an interesting case study you’d like to share,
send Docet a message on LinkedIn.